RPS Advisory Solutions’s iShares Biotechnology ETF IBB Stock Holding History

RPS Advisory Solutions’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Sell	1,736 -46	-3%	-$7.87K	0.17%	72
2025 Q4	$301K	Sell	1,782 -19	-1%	-$3.09K	0.14%	100
2025 Q3	$260K	Sell	1,801 -44	-2%	-$6.01K	0.13%	111
2025 Q2	$233K	Buy	1,845 +127	+7%	+$15.6K	0.13%	93
2025 Q1	$220K	Sell	1,718 -175	-9%	-$23.7K	0.16%	87
2024 Q4	$250K	Sell	1,893 -4	-0.2%	-$562	0.16%	92
2024 Q3	$276K	Sell	1,897 -28	-1%	-$4.05K	0.2%	78
2024 Q2	$264K	Buy	+1,925	New	+$257K	0.24%	71

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RPS Advisory Solutions's IBB Position: Q1 2026 in Review

RPS Advisory Solutions reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q1 2026, selling an estimated $7.87K and leaving 1,736 shares worth $293K. The position accounts for 0.17% of the portfolio, ranked #72.

RPS Advisory Solutions first reported a position in IBB in Q2 2024 and has held it in 8 quarters since. The position peaked at $301K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

RPS Advisory Solutions held 1,736 shares of iShares Biotechnology ETF worth $293K as of Q1 2026.
RPS Advisory Solutions sold 46 iShares Biotechnology ETF shares in Q1 2026, an estimated $7.87K.
iShares Biotechnology ETF made up 0.17% of RPS Advisory Solutions's portfolio in Q1 2026, its #72 holding.
RPS Advisory Solutions first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 8 quarters since.
RPS Advisory Solutions's iShares Biotechnology ETF position peaked at $301K in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on RPS Advisory Solutions's 13F filing for Q1 2026, filed 4 May 2026.